Chinese Japanese Germany Korea

Tofacitinib Impurity 69

Tofacitinib Impurity 69 Structure
Tofacitinib Impurity 69 structure
CAS No.
Chemical Name:
Tofacitinib Impurity 69
Synonyms
Tofacitinib Impurity 69;(E)-2,4-dichlorobut-2-enal
CBNumber:
CB44657804
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
Last updated:2024-05-20 14:01:34
Request For Quotation

Tofacitinib Impurity 69 Preparation Products And Raw materials

Raw materials

Preparation Products

Tofacitinib Impurity 69 Suppliers

Global( 6)Suppliers
Supplier Tel Email Country ProdList Advantage
ShenZhen H&D Pharmaceutical Technology Co., LTD 		+8618627948422 sale@hdimpurity.com China 3389 58
Shenzhen SUNGENING Bio-Medical Co., Ltd. 0755-28967200 13631290199 wxf@sungening.com China 9577 60
Cato Research Chemicals Inc. 020-81215950 4000-868-328 customer@uwalab.com United States 10404 58
Changzhou Xianglong Pharmaceutical Technology Co., LTD 18661161657 yaoxiangqiu2021@163.com China 9996 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 13217415044 wangshuai@hdimpurity.com China 7384 58
Hubei Moco Chemical Co., Ltd. 18627753421 18576690171 3001009495@qq.com China 11202 58
Supplier Advantage
ShenZhen H&D Pharmaceutical Technology Co., LTD 		58
Shenzhen SUNGENING Bio-Medical Co., Ltd. 60
Cato Research Chemicals Inc. 58
Changzhou Xianglong Pharmaceutical Technology Co., LTD 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 58
Hubei Moco Chemical Co., Ltd. 58

View Lastest Price from Tofacitinib Impurity 69 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Tofacitinib Impurity 69 pictures 2024-09-20 Tofacitinib Impurity 69
US $0.00-0.00 / mg 10mg 0.98 10g ShenZhen H&D Pharmaceutical Technology Co., LTD

(Tofacitinib Impurity 69)Related Search:

3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI) (3S,4S)-Tofacitinib 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)- N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile 2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE Tofacitinib Impurity 6

1of4

Tofacitinib Impurity 69 (E)-2,4-dichlorobut-2-enal